683 Capital Management »

Mersana Therapeutics shares owned by 683 Capital Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $776k 100k 7.76

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Schonfeld Strategic Advisors
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics